The agency is reminding medical device companies to evaluate reliability of third-party testing before FDA submission citing uptick of fabricated, duplicated, and unreliable data.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,